Global Anti-Infective Vaccines Market Insights and Forecast to 2026

Global Anti-Infective Vaccines Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Anti-Infective Vaccines Product Introduction
1.2 Market Segments
1.3 Key Anti-Infective Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Infective Vaccines Market Size Growth Rate by Type
1.4.2 Inactivated vaccines
1.4.3 Conjugate vaccines
1.4.4 Live/attenuated vaccines
1.5 Market by Application
1.5.1 Global Anti-Infective Vaccines Market Size Growth Rate by Application
1.5.2 Bacterial diseases
1.5.3 Viral diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Infective Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Anti-Infective Vaccines Revenue 2015-2026
2.1.2 Global Anti-Infective Vaccines Sales 2015-2026
2.2 Global Anti-Infective Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Infective Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-Infective Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Infective Vaccines Competitor Landscape by Players
3.1 Anti-Infective Vaccines Sales by Manufacturers
3.1.1 Anti-Infective Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Anti-Infective Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-Infective Vaccines Revenue by Manufacturers
3.2.1 Anti-Infective Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Anti-Infective Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Infective Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Infective Vaccines Revenue in 2019
3.2.5 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-Infective Vaccines Price by Manufacturers
3.4 Anti-Infective Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Infective Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Infective Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Infective Vaccines Market Size by Type (2015-2020)
4.1.1 Global Anti-Infective Vaccines Sales by Type (2015-2020)
4.1.2 Global Anti-Infective Vaccines Revenue by Type (2015-2020)
4.1.3 Anti-Infective Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Infective Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Infective Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Infective Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Infective Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Infective Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Infective Vaccines Market Size by Application (2015-2020)
5.1.1 Global Anti-Infective Vaccines Sales by Application (2015-2020)
5.1.2 Global Anti-Infective Vaccines Revenue by Application (2015-2020)
5.1.3 Anti-Infective Vaccines Price by Application (2015-2020)
5.2 Anti-Infective Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Infective Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Infective Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Infective Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-Infective Vaccines by Country
6.1.1 North America Anti-Infective Vaccines Sales by Country
6.1.2 North America Anti-Infective Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-Infective Vaccines Market Facts & Figures by Type
6.3 North America Anti-Infective Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-Infective Vaccines by Country
7.1.1 Europe Anti-Infective Vaccines Sales by Country
7.1.2 Europe Anti-Infective Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-Infective Vaccines Market Facts & Figures by Type
7.3 Europe Anti-Infective Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-Infective Vaccines by Region
8.1.1 Asia Pacific Anti-Infective Vaccines Sales by Region
8.1.2 Asia Pacific Anti-Infective Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-Infective Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Anti-Infective Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-Infective Vaccines by Country
9.1.1 Latin America Anti-Infective Vaccines Sales by Country
9.1.2 Latin America Anti-Infective Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-Infective Vaccines Market Facts & Figures by Type
9.3 Central & South America Anti-Infective Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-Infective Vaccines by Country
10.1.1 Middle East and Africa Anti-Infective Vaccines Sales by Country
10.1.2 Middle East and Africa Anti-Infective Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Emergent BioDefense Operations Lansing Inc.
11.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
11.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
11.1.3 Emergent BioDefense Operations Lansing Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
11.1.5 Emergent BioDefense Operations Lansing Inc. Related Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Corporation Information
11.2.2 Sanofi Pasteur Description and Business Overview
11.2.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Pasteur Anti-Infective Vaccines Products Offered
11.2.5 Sanofi Pasteur Related Developments
11.3 Merck & Co.
11.3.1 Merck & Co. Corporation Information
11.3.2 Merck & Co. Description and Business Overview
11.3.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck & Co. Anti-Infective Vaccines Products Offered
11.3.5 Merck & Co. Related Developments
11.4 MedImmune LLC
11.4.1 MedImmune LLC Corporation Information
11.4.2 MedImmune LLC Description and Business Overview
11.4.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 MedImmune LLC Anti-Infective Vaccines Products Offered
11.4.5 MedImmune LLC Related Developments
11.5 Novartis Vaccines
11.5.1 Novartis Vaccines Corporation Information
11.5.2 Novartis Vaccines Description and Business Overview
11.5.3 Novartis Vaccines Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Vaccines Anti-Infective Vaccines Products Offered
11.5.5 Novartis Vaccines Related Developments
11.6 Diagnostics Ltd.
11.6.1 Diagnostics Ltd. Corporation Information
11.6.2 Diagnostics Ltd. Description and Business Overview
11.6.3 Diagnostics Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Diagnostics Ltd. Anti-Infective Vaccines Products Offered
11.6.5 Diagnostics Ltd. Related Developments
11.7 Intercell Biomedical
11.7.1 Intercell Biomedical Corporation Information
11.7.2 Intercell Biomedical Description and Business Overview
11.7.3 Intercell Biomedical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Intercell Biomedical Anti-Infective Vaccines Products Offered
11.7.5 Intercell Biomedical Related Developments
11.8 MassBiologics
11.8.1 MassBiologics Corporation Information
11.8.2 MassBiologics Description and Business Overview
11.8.3 MassBiologics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 MassBiologics Anti-Infective Vaccines Products Offered
11.8.5 MassBiologics Related Developments
11.9 Barr Labs, Inc.
11.9.1 Barr Labs, Inc. Corporation Information
11.9.2 Barr Labs, Inc. Description and Business Overview
11.9.3 Barr Labs, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Barr Labs, Inc. Anti-Infective Vaccines Products Offered
11.9.5 Barr Labs, Inc. Related Developments
11.10 Organon Teknika Co.
11.10.1 Organon Teknika Co. Corporation Information
11.10.2 Organon Teknika Co. Description and Business Overview
11.10.3 Organon Teknika Co. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Organon Teknika Co. Anti-Infective Vaccines Products Offered
11.10.5 Organon Teknika Co. Related Developments
11.1 Emergent BioDefense Operations Lansing Inc.
11.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
11.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
11.1.3 Emergent BioDefense Operations Lansing Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
11.1.5 Emergent BioDefense Operations Lansing Inc. Related Developments
11.12 CSL Ltd.
11.12.1 CSL Ltd. Corporation Information
11.12.2 CSL Ltd. Description and Business Overview
11.12.3 CSL Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 CSL Ltd. Products Offered
11.12.5 CSL Ltd. Related Developments
11.13 ID Biomedical Co.
11.13.1 ID Biomedical Co. Corporation Information
11.13.2 ID Biomedical Co. Description and Business Overview
11.13.3 ID Biomedical Co. Sales, Revenue and Gross Margin (2015-2020)
11.13.4 ID Biomedical Co. Products Offered
11.13.5 ID Biomedical Co. Related Developments
11.14 Protein Sciences Co.
11.14.1 Protein Sciences Co. Corporation Information
11.14.2 Protein Sciences Co. Description and Business Overview
11.14.3 Protein Sciences Co. Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Protein Sciences Co. Products Offered
11.14.5 Protein Sciences Co. Related Developments
11.15 Wyeth Pharmaceuticals, Inc.
11.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
11.15.2 Wyeth Pharmaceuticals, Inc. Description and Business Overview
11.15.3 Wyeth Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Wyeth Pharmaceuticals, Inc. Products Offered
11.15.5 Wyeth Pharmaceuticals, Inc. Related Developments
11.16 Berna Biotech
11.16.1 Berna Biotech Corporation Information
11.16.2 Berna Biotech Description and Business Overview
11.16.3 Berna Biotech Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Berna Biotech Products Offered
11.16.5 Berna Biotech Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-Infective Vaccines Market Estimates and Projections by Region
12.1.1 Global Anti-Infective Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-Infective Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Anti-Infective Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Anti-Infective Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Anti-Infective Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Anti-Infective Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-Infective Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-Infective Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Anti-Infective Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-Infective Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-Infective Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-Infective Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-Infective Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-Infective Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-Infective Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-Infective Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-Infective Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-Infective Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-Infective Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-Infective Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-Infective Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-Infective Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Anti-Infective Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Infective Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Anti-Infective Vaccines Market Segments
Table 2. Ranking of Global Top Anti-Infective Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Infective Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Inactivated vaccines
Table 5. Major Manufacturers of Conjugate vaccines
Table 6. Major Manufacturers of Live/attenuated vaccines
Table 7. Global Anti-Infective Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Anti-Infective Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Anti-Infective Vaccines Sales by Regions 2015-2020 (K Units)
Table 10. Global Anti-Infective Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Anti-Infective Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anti-Infective Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Anti-Infective Vaccines Sales Share by Manufacturers (2015-2020)
Table 14. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Vaccines as of 2019)
Table 16. Anti-Infective Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Anti-Infective Vaccines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Anti-Infective Vaccines Price (2015-2020) (USD/Unit)
Table 19. Anti-Infective Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Anti-Infective Vaccines Product Type
Table 21. Date of International Manufacturers Enter into Anti-Infective Vaccines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-Infective Vaccines Sales by Type (2015-2020) (K Units)
Table 24. Global Anti-Infective Vaccines Sales Share by Type (2015-2020)
Table 25. Global Anti-Infective Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Anti-Infective Vaccines Revenue Share by Type (2015-2020)
Table 27. Anti-Infective Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Anti-Infective Vaccines Sales by Application (2015-2020) (K Units)
Table 29. Global Anti-Infective Vaccines Sales Share by Application (2015-2020)
Table 30. North America Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 31. North America Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 32. North America Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 34. North America Anti-Infective Vaccines Sales by Type (2015-2020) (K Units)
Table 35. North America Anti-Infective Vaccines Sales Market Share by Type (2015-2020)
Table 36. North America Anti-Infective Vaccines Sales by Application (2015-2020) (K Units)
Table 37. North America Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
Table 38. Europe Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 39. Europe Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 40. Europe Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 42. Europe Anti-Infective Vaccines Sales by Type (2015-2020) (K Units)
Table 43. Europe Anti-Infective Vaccines Sales Market Share by Type (2015-2020)
Table 44. Europe Anti-Infective Vaccines Sales by Application (2015-2020) (K Units)
Table 45. Europe Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Anti-Infective Vaccines Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Anti-Infective Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Anti-Infective Vaccines Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Anti-Infective Vaccines Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Anti-Infective Vaccines Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
Table 54. Latin America Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 55. Latin America Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 58. Latin America Anti-Infective Vaccines Sales by Type (2015-2020) (K Units)
Table 59. Latin America Anti-Infective Vaccines Sales Market Share by Type (2015-2020)
Table 60. Latin America Anti-Infective Vaccines Sales by Application (2015-2020) (K Units)
Table 61. Latin America Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anti-Infective Vaccines Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Anti-Infective Vaccines Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
Table 70. Emergent BioDefense Operations Lansing Inc. Corporation Information
Table 71. Emergent BioDefense Operations Lansing Inc. Description and Major Businesses
Table 72. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Emergent BioDefense Operations Lansing Inc. Product
Table 74. Emergent BioDefense Operations Lansing Inc. Recent Development
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Major Businesses
Table 77. Sanofi Pasteur Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Sanofi Pasteur Product
Table 79. Sanofi Pasteur Recent Development
Table 80. Merck & Co. Corporation Information
Table 81. Merck & Co. Description and Major Businesses
Table 82. Merck & Co. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck & Co. Product
Table 84. Merck & Co. Recent Development
Table 85. MedImmune LLC Corporation Information
Table 86. MedImmune LLC Description and Major Businesses
Table 87. MedImmune LLC Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. MedImmune LLC Product
Table 89. MedImmune LLC Recent Development
Table 90. Novartis Vaccines Corporation Information
Table 91. Novartis Vaccines Description and Major Businesses
Table 92. Novartis Vaccines Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Vaccines Product
Table 94. Novartis Vaccines Recent Development
Table 95. Diagnostics Ltd. Corporation Information
Table 96. Diagnostics Ltd. Description and Major Businesses
Table 97. Diagnostics Ltd. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Diagnostics Ltd. Product
Table 99. Diagnostics Ltd. Recent Development
Table 100. Intercell Biomedical Corporation Information
Table 101. Intercell Biomedical Description and Major Businesses
Table 102. Intercell Biomedical Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Intercell Biomedical Product
Table 104. Intercell Biomedical Recent Development
Table 105. MassBiologics Corporation Information
Table 106. MassBiologics Description and Major Businesses
Table 107. MassBiologics Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. MassBiologics Product
Table 109. MassBiologics Recent Development
Table 110. Barr Labs, Inc. Corporation Information
Table 111. Barr Labs, Inc. Description and Major Businesses
Table 112. Barr Labs, Inc. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Barr Labs, Inc. Product
Table 114. Barr Labs, Inc. Recent Development
Table 115. Organon Teknika Co. Corporation Information
Table 116. Organon Teknika Co. Description and Major Businesses
Table 117. Organon Teknika Co. Anti-Infective Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Organon Teknika Co. Product
Table 119. Organon Teknika Co. Recent Development
Table 120. GlaxoSmithKline Biologicals Corporation Information
Table 121. GlaxoSmithKline Biologicals Description and Major Businesses
Table 122. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. GlaxoSmithKline Biologicals Product
Table 124. GlaxoSmithKline Biologicals Recent Development
Table 125. CSL Ltd. Corporation Information
Table 126. CSL Ltd. Description and Major Businesses
Table 127. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. CSL Ltd. Product
Table 129. CSL Ltd. Recent Development
Table 130. ID Biomedical Co. Corporation Information
Table 131. ID Biomedical Co. Description and Major Businesses
Table 132. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. ID Biomedical Co. Product
Table 134. ID Biomedical Co. Recent Development
Table 135. Protein Sciences Co. Corporation Information
Table 136. Protein Sciences Co. Description and Major Businesses
Table 137. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Protein Sciences Co. Product
Table 139. Protein Sciences Co. Recent Development
Table 140. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 141. Wyeth Pharmaceuticals, Inc. Description and Major Businesses
Table 142. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Wyeth Pharmaceuticals, Inc. Product
Table 144. Wyeth Pharmaceuticals, Inc. Recent Development
Table 145. Berna Biotech Corporation Information
Table 146. Berna Biotech Description and Major Businesses
Table 147. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Berna Biotech Product
Table 149. Berna Biotech Recent Development
Table 150. Global Anti-Infective Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 151. Global Anti-Infective Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 152. Global Anti-Infective Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 153. Global Anti-Infective Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 154. North America: Anti-Infective Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 155. North America: Anti-Infective Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Europe: Anti-Infective Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 157. Europe: Anti-Infective Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Asia Pacific: Anti-Infective Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 159. Asia Pacific: Anti-Infective Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 160. Latin America: Anti-Infective Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 161. Latin America: Anti-Infective Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Middle East and Africa: Anti-Infective Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 163. Middle East and Africa: Anti-Infective Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 165. Key Challenges
Table 166. Market Risks
Table 167. Main Points Interviewed from Key Anti-Infective Vaccines Players
Table 168. Anti-Infective Vaccines Customers List
Table 169. Anti-Infective Vaccines Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Infective Vaccines Product Picture
Figure 2. Global Anti-Infective Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Inactivated vaccines Product Picture
Figure 4. Conjugate vaccines Product Picture
Figure 5. Live/attenuated vaccines Product Picture
Figure 6. Global Anti-Infective Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Bacterial diseases
Figure 8. Viral diseases
Figure 9. Anti-Infective Vaccines Report Years Considered
Figure 10. Global Anti-Infective Vaccines Market Size 2015-2026 (US$ Million)
Figure 11. Global Anti-Infective Vaccines Sales 2015-2026 (K Units)
Figure 12. Global Anti-Infective Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Anti-Infective Vaccines Sales Market Share by Region (2015-2020)
Figure 14. Global Anti-Infective Vaccines Sales Market Share by Region in 2019
Figure 15. Global Anti-Infective Vaccines Revenue Market Share by Region (2015-2020)
Figure 16. Global Anti-Infective Vaccines Revenue Market Share by Region in 2019
Figure 17. Global Anti-Infective Vaccines Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Anti-Infective Vaccines Revenue in 2019
Figure 19. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Anti-Infective Vaccines Sales Market Share by Type (2015-2020)
Figure 21. Global Anti-Infective Vaccines Sales Market Share by Type in 2019
Figure 22. Global Anti-Infective Vaccines Revenue Market Share by Type (2015-2020)
Figure 23. Global Anti-Infective Vaccines Revenue Market Share by Type in 2019
Figure 24. Global Anti-Infective Vaccines Market Share by Price Range (2015-2020)
Figure 25. Global Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
Figure 26. Global Anti-Infective Vaccines Sales Market Share by Application in 2019
Figure 27. Global Anti-Infective Vaccines Revenue Market Share by Application (2015-2020)
Figure 28. Global Anti-Infective Vaccines Revenue Market Share by Application in 2019
Figure 29. North America Anti-Infective Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Anti-Infective Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Anti-Infective Vaccines Sales Market Share by Country in 2019
Figure 32. North America Anti-Infective Vaccines Revenue Market Share by Country in 2019
Figure 33. U.S. Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Anti-Infective Vaccines Market Share by Type in 2019
Figure 38. North America Anti-Infective Vaccines Market Share by Application in 2019
Figure 39. Europe Anti-Infective Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Anti-Infective Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Anti-Infective Vaccines Sales Market Share by Country in 2019
Figure 42. Europe Anti-Infective Vaccines Revenue Market Share by Country in 2019
Figure 43. Germany Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Anti-Infective Vaccines Market Share by Type in 2019
Figure 54. Europe Anti-Infective Vaccines Market Share by Application in 2019
Figure 55. Asia Pacific Anti-Infective Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Anti-Infective Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region in 2019
Figure 58. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region in 2019
Figure 59. China Anti-Infective Vaccines Sales Growth Rate (2

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs